Related references
Note: Only part of the references are listed.AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway Bin
Bin Liu et al.
EXPERIMENTAL NEUROLOGY (2020)
Modulation of Glucose Metabolism in Hippocampal Neurons by Adiponectin and Resistin
Pedro Cisternas et al.
MOLECULAR NEUROBIOLOGY (2019)
Thiazolidinedione as an alternative to facilitate oral administration in geriatric patients with Alzheimer's disease
Marcelle Silva-Abreu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Liraglutide and its Neuroprotective PropertiesFocus on Possible Biochemical Mechanisms in Alzheimer's Disease and Cerebral Ischemic Events
Michal Wicinski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives
Hidekatsu Yanai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease
Gifty M. Jojo et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer's disease
Elena P. Moreno-Jimenez et al.
NATURE MEDICINE (2019)
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
D. Allan Butterfield et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Adiponectin Protects Against Cerebral Ischemic Injury Through AdipoR1/AMPK Pathways
Bin Liu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Adiponectin improves long-term potentiation in the 5XFAD mouse brain
Ming Wang et al.
SCIENTIFIC REPORTS (2019)
DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling
Shuyi Chen et al.
NEUROPHARMACOLOGY (2019)
Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting
Yao Zhang et al.
NEUROSCIENCE BULLETIN (2019)
Adiponectin Attenuates Streptozotocin-Induced Tau Hyperphosphorylation and Cognitive Deficits by Rescuing PI3K/Akt/GSK-3β Pathway
Zhi-Peng Xu et al.
NEUROCHEMICAL RESEARCH (2018)
Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia
Fabricio Ferreira de Oliveira et al.
CURRENT ALZHEIMER RESEARCH (2018)
Targeting PPARalpha in Alzheimer's Disease
Barbara D'Orio et al.
CURRENT ALZHEIMER RESEARCH (2018)
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
Andre F. Batista et al.
JOURNAL OF PATHOLOGY (2018)
Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke
David Sacks et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
The Adiponectin Homolog Osmotin Enhances Neurite Outgrowth and Synaptic Complexity via AdipoR1/NgR1 Signaling in Alzheimer's Disease
Gwangho Yoon et al.
MOLECULAR NEUROBIOLOGY (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
Overexpression of adiponectin alleviates intracerebral hemorrhage-induced brain injury in rats via suppression of oxidative stress
Shaohua Wang et al.
NEUROSCIENCE LETTERS (2018)
Association of adiponectin with cognitive function precedes overt diabetes in the Brazilian Longitudinal Study of Adult Health: ELSA
Adriana Cezaretto et al.
DIABETOLOGY & METABOLIC SYNDROME (2018)
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation
Francesca Romana Rizzo et al.
NEURAL PLASTICITY (2018)
Metformin, sitagliptin, and liraglutide modulate serum retinol-binding protein-4 level and adipocytokine production in type 2 diabetes mellitus rat model
Noha A. T. Abbas et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2018)
Mechanism of NMDA receptor channel block by MK-801 and memantine
Xianqiang Song et al.
NATURE (2018)
Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer's mouse model
Se Hoon Choi et al.
SCIENCE (2018)
Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats
Jia Li et al.
JOURNAL OF DIABETES RESEARCH (2018)
Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression
Sarah Nicolas et al.
TRANSLATIONAL PSYCHIATRY (2018)
Assessment of Cognitive Impairment in a Mouse Model of High-Fat Diet-Induced Metabolic Stress with Touchscreen-Based Automated Battery System
Saeram Lee et al.
EXPERIMENTAL NEUROBIOLOGY (2018)
Adiponectin confers neuroprotection against cerebral ischemia-reperfusion injury through activating the cAMP/PKA-CREB-BDNF signaling
Hao Bai et al.
BRAIN RESEARCH BULLETIN (2018)
Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications
Andrea Tumminia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers
Sanaz Nasoohi et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
DPP-4 inhibitors: a promising therapeutic approach against Alzheimer's disease
Efthalia Angelopoulou et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans
Min Yi et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease
Suzanne M. de la Monte
DRUGS (2017)
Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease
Jayasankar Kosaraju et al.
MOLECULAR NEUROBIOLOGY (2017)
Adiponectin regulates contextual fear extinction and intrinsic excitability of dentate gyrus granule neurons through AdipoR2 receptors
D. Zhang et al.
MOLECULAR PSYCHIATRY (2017)
Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits
S. A. Shah et al.
MOLECULAR PSYCHIATRY (2017)
Novel Insights in the Metabolic Syndrome in Childhood and Adolescence
Sarah Bussler et al.
HORMONE RESEARCH IN PAEDIATRICS (2017)
Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition
Rebecca F. Gottesman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease
Eric Tonnies et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Amyloid β-42 induces neuronal apoptosis by targeting mitochondria
Xiao-Jian Han et al.
MOLECULAR MEDICINE REPORTS (2017)
The effects of oxytocin on eating behaviour and metabolism in humans
Elizabeth A. Lawson
NATURE REVIEWS ENDOCRINOLOGY (2017)
Globular Adiponectin Limits Microglia Pro-Inflammatory Phenotype through an AdipoR1/NF-κB Signaling Pathway
Sarah Nicolas et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Adiponectin Receptors Are Less Sensitive to Stress in a Transgenic Mouse Model of Alzheimer's Disease
Zoltan P. Varhelyi et al.
FRONTIERS IN NEUROSCIENCE (2017)
Impact of Orexin-A Treatment on Food Intake, Energy Metabolism and Body Weight in Mice
Anne Blais et al.
PLOS ONE (2017)
Exendin-4 Upregulates Adiponectin Level in Adipocytes via Sirt1/Foxo-1 Signaling Pathway
Anping Wang et al.
PLOS ONE (2017)
Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome
Gema Fruhbeck et al.
SCIENTIFIC REPORTS (2017)
Suppression of adiponectin receptor 1 promotes memory dysfunction and Alzheimer's disease-like pathologies
Min Woo Kim et al.
SCIENTIFIC REPORTS (2017)
The effects of sitagliptin, a DPP-4 inhibitor, on cognitive functions in elderly diabetic patients with or without Alzheimer's disease
Ahmet Turan Isik et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Fibrates in the management of atherogenic dyslipidemia
Boguslaw Okopien et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2017)
Effects of short-term add-on ezetimibe to statin treatment on expression of adipokines and inflammatory markers in diabetic and dyslipidemic patients
Elizandra Silva Guimaraes et al.
CARDIOVASCULAR THERAPEUTICS (2017)
Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration
Brina Snyder et al.
PHYSIOLOGICAL REPORTS (2017)
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease
Subbiah Pugazhenthi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Serum high-molecular-weight adiponectin level and incident dementia in patients with vascular risk factors
K. Kitagawa et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
The genetic landscape of Alzheimer disease: clinical implications and perspectives
Caroline Van Cauwenberghe et al.
GENETICS IN MEDICINE (2016)
A high-sugar high-fat diet induced metabolic syndrome shows some symptoms of Alzheimer's disease in rats
L. Niu et al.
JOURNAL OF NUTRITION HEALTH & AGING (2016)
Adiponectin, leptin and IL-1 β in elderly diabetic patients with mild cognitive impairment
Malgorzata Gorska-Ciebiada et al.
METABOLIC BRAIN DISEASE (2016)
Detrimental effects of a high fat/high cholesterol diet on memory and hippocampal markers in aged rats
Aurelie Ledreux et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Angiotensin converting enzyme serum activities: Relationship with Alzheimer's disease
Shan Zhuang et al.
BRAIN RESEARCH (2016)
Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer's Disease
Juan M. Saavedra
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
Peripheral Blood Adipokines and Insulin Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analysis
Jing Ma et al.
CURRENT ALZHEIMER RESEARCH (2016)
Effect of Dipeptidyl Peptidase-4 Inhibitors on Plasma Adiponectin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Amirhossein Sahebkar et al.
CURRENT MEDICINAL CHEMISTRY (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Adiponectin Exerts Neurotrophic Effects on Dendritic Arborization, Spinogenesis, and Neurogenesis of the Dentate Gyrus of Male Mice
Di Zhang et al.
ENDOCRINOLOGY (2016)
Metformin activation of AMPK-dependent pathways is neuroprotective in human neural stem cells against Amyloid-beta-induced mitochondrial dysfunction
Ming-Chang Chiang et al.
EXPERIMENTAL CELL RESEARCH (2016)
An update on DPP-4 inhibitors in the management of type 2 diabetes
Avivit Cahn et al.
EXPERT OPINION ON EMERGING DRUGS (2016)
Relationship of Serum Adiponectin Levels and Metformin Therapy in Patients with Type 2 Diabetes
J. -R. Su et al.
HORMONE AND METABOLIC RESEARCH (2016)
Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease
Masaaki Waragai et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging
Alexandra M. V. Wennberg et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
Jose A. Luchsinger et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
The association of renin-angiotensin system blockade use with the risks of cognitive impairment of aging and Alzheimer's disease: A meta-analysis
Shan Zhuang et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
Alzheimer's like brain changes correlate with low adiponectin plasma levels in type 2 diabetic patients
Natalia Garcia-Casares et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Adiponectin Inhibits LPS-Induced HMGB1 Release through an AMP Kinase and Heme Oxygenase-1-Dependent Pathway in RAW 264 Macrophage Cells
Mohamed Elfeky et al.
MEDIATORS OF INFLAMMATION (2016)
Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice
Roy Chun-Laam Ng et al.
MOLECULAR NEURODEGENERATION (2016)
Adiponectin Protects against Glutamate-Induced Excitotoxicity via Activating SIRT1-Dependent PGC-1 alpha Expression in HT22 Hippocampal Neurons
Liang Yue et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway
Haroon Badshah et al.
SCIENTIFIC REPORTS (2016)
Exenatide Activates the APPL1-AMPK-PPARα Axis to Prevent Diabetic Cardiomyocyte Apoptosis
Lei XiaoTian et al.
JOURNAL OF DIABETES RESEARCH (2016)
The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent
Ming-Min Chung et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Enriched environment decreases microglia and brain macrophages inflammatory phenotypes through adiponectin-dependent mechanisms: Relevance to depressive-like behavior
Joelle Chabry et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
New cardiovascular targets to prevent late onset Alzheimer disease
Jurgen A. H. R. Claassen
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond
Donna Ryan et al.
OBESITY (2015)
Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-Analysis
Wen Kong et al.
PLOS ONE (2015)
Adiponectin receptor-mediated signaling ameliorates cerebral cell damage and regulates the neurogenesis of neural stem cells at high glucose concentrations: an in vivo and in vitro study
J. Song et al.
CELL DEATH & DISEASE (2015)
Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus
Tahir Ali et al.
SCIENTIFIC REPORTS (2015)
Inhibition of ACE Retards Tau Hyperphosphorylation and Signs of Neuronal Degeneration in Aged Rats Subjected to Chronic Mild Stress
Said AbdAlla et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Candesartan Improves Ischemia-Induced Impairment of the Blood-Brain Barrier In Vitro
Gohei So et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2015)
2003-2013: A Decade of Body Mass Index, Alzheimer's Disease, and Dementia
Tim L. Emmerzaal et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug
Mennatallah A. Ali et al.
PLOS ONE (2015)
Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease
Sergio T. Ferreira et al.
ALZHEIMERS & DEMENTIA (2014)
Effects of Angiotensin-Converting Enzyme Inhibition on Leptin and Adiponectin Levels in Essential Hypertension
Vanessa Fontana et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Adiponectin receptors: A review of their structure, function and how they work
Toshimasa Yamauchi et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Serum Adipokine Levels Modified by Donepezil Treatment in Alzheimer's Disease
Magdolna Pakaski et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Altered Serum Levels of Adipokines and Insulin in Probable Alzheimer's Disease
Vineet Kumar Khemka et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight
Laurie L. Baggio et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline
Kenneth E. Bernstein et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Adipocytokines in obesity and metabolic disease
Haiming Cao
JOURNAL OF ENDOCRINOLOGY (2014)
Conversion of Aβ43 to Aβ40 by the Successive Action of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme
Shuyu Liu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model
Brice Ongali et al.
NEUROBIOLOGY OF DISEASE (2014)
Novel osmotin attenuates glutamate-induced synaptic dysfunction and neurodegeneration via the JNK/PI3K/Akt pathway in postnatal rat brain
S. A. Shah et al.
CELL DEATH & DISEASE (2014)
Fatty Acids in Energy Metabolism of the Central Nervous System
Alexander Panov et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Disease modifying effect of adiponectin in model of α-synucleinopathies
Kazunari Sekiyama et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
The role of leptin/adiponectin ratio in metabolic syndrome and diabetes
Patricio Lopez-Jaramillo et al.
HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION (2014)
Fibrate therapy and circulating adiponectin concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials
Amirhossein Sahebkar et al.
ATHEROSCLEROSIS (2013)
Adiponectin Receptor as a Key Player in Healthy Longevity and Obesity-Related Diseases
Toshimasa Yamauchi et al.
CELL METABOLISM (2013)
TNF-α Mediates PKR-Dependent Memory Impairment and Brain IRS-1 Inhibition Induced by Alzheimer's β-Amyloid Oligomers in Mice and Monkeys
Mychael V. Lourenco et al.
CELL METABOLISM (2013)
Angiotensin-Receptor Blockers and Risk of Alzheimer's Disease in Hypertension Population - A Nationwide Cohort Study
Chien-Yi Hsu et al.
CIRCULATION JOURNAL (2013)
Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle-Aged Adults
Auriel A. Willette et al.
DIABETES CARE (2013)
ACE Inhibition with Captopril Retards the Development of Signs of Neurodegeneration in an Animal Model of Alzheimer's Disease
Said AbdAlla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Hypoxia-inducible Factor 1α Regulates a SOCS3-STAT3-Adiponectin Signal Transduction Pathway in Adipocytes
Changtao Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
T-cadherin Is Essential for Adiponectin-mediated Revascularization
Jennifer L. Parker-Duffen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Why does brain metabolism not favor burning of fatty acids to provide energy? - Reflections on disadvantages of the use of free fatty acids as fuel for brain
Peter Schoenfeld et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Alzheimer's disease and insulin resistance: translating basic science into clinical applications
Fernanda G. De Felice
JOURNAL OF CLINICAL INVESTIGATION (2013)
Angiotensin-Converting Enzyme Inhibitors and Alzheimer's Disease Progression in Older Adults: Results from the Reseau sur la Maladie d'Alzheimer Francais Cohort
Maria E. Soto et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2013)
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
Miki Okada-Iwabu et al.
NATURE (2013)
Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats
Wei-Na Han et al.
NEUROBIOLOGY OF AGING (2013)
Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer's Disease
Antonio L. Teixeira et al.
NEUROMOLECULAR MEDICINE (2013)
Adiponectin as a new paradigm for approaching Alzheimer's disease
Juhyun Song et al.
ANATOMY & CELL BIOLOGY (2013)
Biomarkers for Insulin Resistance and Inflammation and the Risk for All-Cause Dementia and Alzheimer Disease Results From the Framingham Heart Study
Thomas M. van Himbergen et al.
ARCHIVES OF NEUROLOGY (2012)
Adiponectin receptor signalling in the brain
John Thundyil et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
Christian Hölscher
CNS DRUGS (2012)
Adiponectin: mechanistic insights and clinical implications
A. T. Turer et al.
DIABETOLOGIA (2012)
Association between hippocampal volume and serum adiponectin in patients with type 2 diabetes mellitus
Takayuki Masaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Adiponectin is Protective against Oxidative Stress Induced Cytotoxicity in Amyloid-Beta Neurotoxicity
Koon-Ho Chan et al.
PLOS ONE (2012)
Metformin attenuates Alzheimer's disease-like neuropathology in obese, leptin-resistant mice
Jiejie Li et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Novel links between HIFs, type 2 diabetes, and metabolic syndrome
Christian M. Girgis et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Adiponectin protects rat hippocampal neurons against excitotoxicity
Guang Qiu et al.
AGE (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Obesity, leptin, and Alzheimer's disease
Edward B. Lee
YEAR IN DIABETES AND OBESITY (2011)
Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease
K. Une et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease
Yi-Fei Dong et al.
FASEB JOURNAL (2011)
AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function
D. Grahame Hardie
GENES & DEVELOPMENT (2011)
Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin
Chih-Cheng Hsu et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations
Cristiane de Oliveira et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes
Amit Gupta et al.
NEUROPHARMACOLOGY (2011)
Brain fuel metabolism, aging, and Alzheimer's disease
Stephen Cunnane et al.
NUTRITION (2011)
Adipocytokines and CD34+ Progenitor Cells in Alzheimer's Disease
Boris Bigalke et al.
PLOS ONE (2011)
Globular Adiponectin, Acting via AdipoR1/APPL1, Protects H9c2 Cells from Hypoxia/Reoxygenation-Induced Apoptosis
Min Park et al.
PLOS ONE (2011)
AMPK and SIRT1: a long-standing partnership?
Neil B. Ruderman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Meta-Analysis of Alzheimer's Disease Risk with Obesity, Diabetes, and Related Disorders
Louis A. Profenno et al.
BIOLOGICAL PSYCHIATRY (2010)
Abdominal Fat, Adipose-Derived Hormones and Mild Cognitive Impairment: The J-SHIPP Study
Kenji Kamogawa et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
Obesity: A Complex Growing Challenge
Z. Pataky et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling
Eva Kickstein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Anti-Inflammatory Effects of Angiotensin Receptor Blockers in the Brain and the Periphery
Julius Benicky et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2009)
Clearance of Amyloid-beta Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease
R. Deane et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis
Yun Hu et al.
DIABETES & VASCULAR DISEASE RESEARCH (2009)
Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome
F. Montecucco et al.
DIABETES OBESITY & METABOLISM (2009)
Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure
Takayoshi Tsutamoto et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Angiotensin Receptor Blocker Prevented β-Amyloid-Induced Cognitive Impairment Associated With Recovery of Neurovascular Coupling
Shuko Takeda et al.
HYPERTENSION (2009)
Angiotensin-Converting Enzyme (ACE) Inhibitors Modulate Cellular Retinol-Binding Protein 1 and Adiponectin Expression in Adipocytes via the ACE-Dependent Signaling Cascade
Karin Kohlstedt et al.
MOLECULAR PHARMACOLOGY (2009)
NEUROSCIENCE Alzheimer's disease
Lennart Mucke
NATURE (2009)
Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
Alison Hamilton et al.
NEUROREPORT (2009)
Effect of Atorvastatin Versus Rosuvastatin on Levels of Serum Lipids, Inflammatory Markers and Adiponectin in Patients with Hypercholesterolemia
Hai-yan Qu et al.
PHARMACEUTICAL RESEARCH (2009)
Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers
Fernanda G. De Felice et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: An observational study
Ihab M. Hajjar et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2008)
Telmisartan prevented cognitive decline partly due to PPAR-γ activation
Masaki Mogi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
The Adiponectin Receptors AdipoR1 and AdipoR2 Activate ERK1/2 through a Src/Ras-Dependent Pathway and Stimulate Cell Growth
Mi-Hye Lee et al.
BIOCHEMISTRY (2008)
Comparison of the effect of lipophilic and hydrophilic statins on serum adiponectin levels in patients with mild hypertension and dyslipidemia: Kinki Adiponectin Interventional (KAI) Study
Tatsuya Kai et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2008)
GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid
Victor A. Gault et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
AdipoR1 mediates the anorexigenic and insulin/leptin-like actions of adiponectin in the hypothalamus
Andressa Coope et al.
FEBS LETTERS (2008)
Adiponectin Blocks Interleukin-18-mediated Endothelial Cell Death via APPL1-dependent AMP-activated Protein Kinase (AMPK) Activation and IKK/NF-κB/PTEN Suppression
Bysani Chandrasekar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Angiotensin-converting enzyme converts amyloid β-protein 1-42 (Aβ1-42) to Aβ1-40, and its inhibition enhances brain aβ deposition
Kun Zou et al.
JOURNAL OF NEUROSCIENCE (2007)
Potential effects of angiotensin II receptor blockers on glucose tolerance and adiponectin levels in hypertensive patients
Shinji Makita et al.
CARDIOVASCULAR DRUGS AND THERAPY (2007)
Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid
Hiroyuki Ebinuma et al.
CLINICAL CHEMISTRY (2007)
Adiponectin stimulates AMP-Activated protein kinase in the hypothalamus and increases food intake
Naoto Kubota et al.
CELL METABOLISM (2007)
Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells
Kenneth K. Y. Cheng et al.
DIABETES (2007)
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions
Toshimasa Yamauchi et al.
NATURE MEDICINE (2007)
Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy
TracyAnn Perry et al.
EXPERIMENTAL NEUROLOGY (2007)
Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPAR-γ
Stefan Zorad et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Developing a head for energy sensing: AMP-activated protein kinase as a multifunctional metabolic sensor in the brain
Santosh Ramamurthy et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function
XM Mao et al.
NATURE CELL BIOLOGY (2006)
Peroxisome proliferator-activated receptor (PPAR)α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue -: Comparison of activation of PPARα, PPAR-γ, and their combination
A Tsuchida et al.
DIABETES (2005)
PPAR γ-activating angiotensin type-1 receptor blockers induce adiponectin
R Clasen et al.
HYPERTENSION (2005)
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?
E Steen et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
Increased risk of type 2 diabetes in Alzheimer disease
J Janson et al.
DIABETES (2004)
Pathways towards and away from Alzheimer's disease
MP Mattson
NATURE (2004)
Nutrition during brain activation: does cell-to-cell lactate shuttling contribute significantly to sweet and sour food for thought?
GA Dienel et al.
NEUROCHEMISTRY INTERNATIONAL (2004)
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During et al.
NATURE MEDICINE (2003)
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
T Yamauchi et al.
NATURE (2003)
Microglial activation and amyloid-β clearance induced by exogenous heat-shock proteins
J Kakimura et al.
FASEB JOURNAL (2002)
Glucose and lactate metabolism during brain activation
GA Dienel et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
T Yamauchi et al.
NATURE MEDICINE (2001)
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
AH Berg et al.
NATURE MEDICINE (2001)
Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys
K Hotta et al.
DIABETES (2001)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review
JM Malinowski et al.
CLINICAL THERAPEUTICS (2000)
Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages
T Yokota et al.
BLOOD (2000)
Share Paper
